People

Oliver Eng, MD

  • Assistant Professor of Surgery
  • Research and Scholarly Interests: Appendix Cancer, Cancer of the Gastrointestinal Tract, Colon Cancer, Cytoreductive Surgery, Gastric Cancer, Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Metastasectomy, Peritoneal Disease, Peritoneal Mesothelioma, Retroperitoneal Neoplasms
  • Websites: Research Network Profile
  • Contact: oeng@surgery.bsd.uchicago.edu

Oliver Eng, MD, is a double board-certified surgeon and surgical oncologist who focuses on the treatment of cancers in the abdomen, and in particular, cancers that have spread to the peritoneum, the membrane that lines the abdominal cavity. He specializes in complex cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC) for locally advanced and metastatic cancers which have disseminated in the abdomen. HIPEC entails delivering high-dose heated chemotherapy in the operating room after surgical removal of visible disease, and is effective in different types of cancers.



Dr. Eng treats a variety of abdominal cancers and is skilled at minimally invasive robotic approaches for gastrointestinal and hepatobiliary malignancies, which enables the removal of tumors through small incisions. He also has expertise in the management of sarcomas, neuroendocrine tumors, metastatic cancers to the liver and malignant bowel obstructions.



Dr. Eng has published numerous peer-reviewed manuscripts in journals, including JAMA Surgery and Annals of Surgical Oncology. His research centers on better understanding the molecular and immunologic characteristics of peritoneal tumors, as well as optimizing outcomes and care for cancer patients. His work has been presented nationally and internationally, and he is the principal investigator or co-investigator on multiple clinical trials. He has co-authored many book chapters and serves as a reviewer for a variety of scientific journals.

City of Hope National Medical Center
- Fellowship

Rutgers University - Robert Wood Johnson Medical School
- Residency

Rutgers University - Robert Wood Johnson Medical School
- MD

Brown University
- ScB

Cancer Surgery During COVID-19: How We Move Forward.
Eng OS, Pawlik TM, Ejaz A. Cancer Surgery During COVID-19: How We Move Forward. Ann Surg. 2020 May 20.
PMID: 32433289

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Technical considerations and the learning curve.
Vining CC, Izquierdo F, Eng OS, Turaga KK. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Technical considerations and the learning curve. J Surg Oncol. 2020 May 20.
PMID: 32436240

Apples to Oranges: Ethical Considerations in COVID-19 Surgical Recovery.
Eng OS, Tseng J, Ejaz A, Pawlik TM, Angelos P. Apples to Oranges: Ethical Considerations in COVID-19 Surgical Recovery. Ann Surg. 2020 May 20.
PMID: 32433303

Virtual Surgical Fellowship Recruitment During COVID-19 and Its Implications for Resident/Fellow Recruitment in the Future.
Vining CC, Eng OS, Hogg ME, Schuitevoerder D, Silverman RS, Yao KA, Winchester DJ, Roggin KK, Talamonti MS, Posner MC, Turaga KK, Tseng J. Virtual Surgical Fellowship Recruitment During COVID-19 and Its Implications for Resident/Fellow Recruitment in the Future. Ann Surg Oncol. 2020 May 18.
PMID: 32424589

Virtual Surgical Fellowship Recruitment During COVID-19 and Its Implications for Resident/Fellow Recruitment in the Future.
Vining CC, Eng OS, Hogg ME, Schuitevoerder D, Silverman RS, Yao KA, Winchester DJ, Roggin KK, Talamonti MS, Posner MC, Turaga KK, Tseng J. Virtual Surgical Fellowship Recruitment During COVID-19 and Its Implications for Resident/Fellow Recruitment in the Future. Ann Surg Oncol. 2020 May 18; 1-5.
PMID: 32425476

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms.
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms. Ann Surg Oncol. 2020 Jun; 27(6):1753-1760.
PMID: 32285275

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms.
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms. Ann Surg Oncol. 2020 Jun; 27(6):1780-1787.
PMID: 32285271

The Chicago Consensus on peritoneal surface malignancies: Management of neuroendocrine tumors.
The Chicago Consensus on peritoneal surface malignancies: Management of neuroendocrine tumors. Cancer. 2020 Jun 01; 126(11):2561-2565.
PMID: 32282069

The Chicago Consensus on peritoneal surface malignancies: Palliative care considerations.
The Chicago Consensus on peritoneal surface malignancies: Palliative care considerations. Cancer. 2020 Jun 01; 126(11):2571-2576.
PMID: 32282059

The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma.
The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma. Cancer. 2020 Jun 01; 126(11):2547-2552.
PMID: 32282077

View All Publications